Stratec SE - Unsponsored ADR logo

Stratec SE - Unsponsored ADR (STSEY)

Market Closed
2 Jun, 20:00
OTC PINK OTC PINK
$
5. 5100
0
0%
$
1.67B Market Cap
- P/E Ratio
0.3% Div Yield
100 Volume
- Eps
$ 5.51
Previous Close
Add Transaction
Day Range
5.51 5.51
Year Range
5 6.7
Want to track STSEY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

STSEY closed yesterday higher at $5.51, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, STSEY stock gained 10.2%.
STSEY pays dividends to its shareholders, with the most recent payment made on Jul 17, 2025. The next estimated payment will be in In 1 month on Jul 17, 2026 for a total of $0.13614.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

STSEY Chart

People also search for

VTech Holdings Ltd.
$ 7.8
0%
Shandong Weigao Group - Unsponsored ADR
$ 1.74
0%
Anritsu Corp.
$ 13.71
0%
Top Glove Corporation Bhd Sponsored ADR
$ 0.76
+9.88%
VTech Holdings Limited Unsponsored ADR
$ 7.06
+5.53%

Stratec SE - Unsponsored ADR (STSEY) FAQ

What is the stock price today?

The current price is $5.5100.

On which exchange is it traded?

Stratec SE - Unsponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is STSEY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.3%.

What is its market cap?

As of today, the market cap is 1.67B.

Has Stratec SE - Unsponsored ADR ever had a stock split?

No, there has never been a stock split.

Stratec SE - Unsponsored ADR Profile

Technology Hardware, Storage & Peripherals Industry
Information Technology Sector
Marcus Wolfinger CEO
OTC PINK Exchange
86272N109 CUSIP
DE Country
1,462 Employees
1 Jul 2025 Last Dividend
- Last Split
- IPO Date

Overview

Stratec SE is a pivotal enterprise in the global medical and diagnostic sectors, recognized for its innovative automation and instrumentation solutions. Headquartered in Birkenfeld, Germany, the company boasts an international presence, illustrating a robust commitment to advancing the fields of in-vitro diagnostics and life sciences. Founded in 1979, Stratec has undergone significant evolution, most notably transitioning from its earlier identity as STRATEC Biomedical AG to its current designation, Stratec SE, in December 2018. This rebranding underscored its expansive scope of operations, which are neatly categorized into three primary segments: Instrumentation, Diatron, and Smart Consumables, each tailored to meet specific industry demands while synergizing to reinforce Stratec's market position within Germany, the European Union, and beyond.

Products and Services

  • Instrumentation

    This segment represents the core of Stratec's operations, focusing on the design and manufacturing of automated analyzer systems. These sophisticated systems serve a vital purpose in clinical diagnostics and biotechnology, enabling efficient, accurate testing results. Alongside these systems, Stratec also offers an assortment of service parts and consumables, catering to the ongoing operational needs of their customers. This comprehensive support ensures not only the functionality of their instrumentation but also its relevancy and adaptability to advancements within the scientific community.

  • Diatron

    Specifically targeting the low throughput segment, the Diatron division provides a suite of solutions designed for efficiency and accuracy on a smaller scale. This includes a range of systems, system components, consumables, and tests, all tailored to meet the unique demands of diagnostic and research environments with lower volume requirements. Such offerings make precision diagnostics accessible to more facilities, extending the reach of advanced medical technology.

  • Smart Consumables

    The innovative edge of Stratec is most evident in its Smart Consumables segment. Here, the company leverages its expertise in diagnostics, life sciences, and medical technologies to develop and manufacture 'smart' consumables. These products are characterized by their integration of advanced materials and technologies that enhance the performance and capabilities of diagnostic and research applications. This forward-thinking approach reflects Stratec's commitment to pioneering solutions that meet the evolving needs of the healthcare and research industries.

Contact Information

Address: Gewerbestrasse 37
Phone: 49 7082 7916 0